BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23201053)

  • 1. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.
    Nogueiras-Nieto L; Begoña Delgado-Charro M; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2013 Apr; 83(3):370-7. PubMed ID: 23201053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
    Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
    Cutrín-Gómez E; Conde-Penedo A; Anguiano-Igea S; Gómez-Amoza JL; Otero-Espinar FJ
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration.
    Gómez EC; Anguiano Igea S; Gómez Amoza JL; Otero Espinar FJ
    Eur J Pharm Sci; 2018 May; 117():270-278. PubMed ID: 29501459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
    Täuber A; Müller-Goymann CC
    Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
    Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
    Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer.
    Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30208659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state.
    Nogueiras-Nieto L; Alvarez-Lorenzo C; Sandez-Macho I; Concheiro A; Otero-Espinar FJ
    J Phys Chem B; 2009 Mar; 113(9):2773-82. PubMed ID: 19708112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
    Täuber A; Müller-Goymann CC
    Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A; Müller-Goymann CC
    Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
    Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
    Sidou F; Soto P
    Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
    Palliyil B; Lebo DB; Patel PR
    AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclopirox delivery into the human nail plate.
    Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
    J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer.
    Togni G; Mailland F
    J Drugs Dermatol; 2010 May; 9(5):525-30. PubMed ID: 20480796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.
    Monti D; Tampucci S; Chetoni P; Burgalassi S; Mailland F
    J Drugs Dermatol; 2014 Feb; 13(2):143-7. PubMed ID: 24509963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.